1,485
Views
11
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy

, , , , , , , , & show all
Pages 543-550 | Received 09 Aug 2016, Accepted 04 Oct 2016, Published online: 19 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jun-Chen Liu & Hong-Jing Yu. (2023) A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors. Pharmacogenomics and Personalized Medicine 16, pages 29-36.
Read now
Yang He, Yi Ding, Bo Cao, Yi Huang & Xiao Wang. (2021) COVID-19 vaccine development from the perspective of cancer patients. Human Vaccines & Immunotherapeutics 17:10, pages 3281-3287.
Read now
Mohammad Bosaeed & Deepali Kumar. (2018) Seasonal influenza vaccine in immunocompromised persons. Human Vaccines & Immunotherapeutics 14:6, pages 1311-1322.
Read now

Articles from other publishers (8)

Kei Nakashima, Yuya Homma, Jumpei Taniguchi, Norihiko Kubota, Ayumu Otsuki, Hiroyuki Ito, Yoshihito Otsuka, Kyoko Kondo, Satoko Ohfuji, Wakaba Fukushima & Yoshio Hirota. (2023) Immunogenicity and safety of influenza vaccine in patients with lung cancer receiving immune checkpoint inhibitors: A single-center prospective cohort study. Journal of Infection and Chemotherapy 29:11, pages 1038-1045.
Crossref
P. Pedrazzoli, A. Lasagna, I. Cassaniti, A. Piralla, A. Squeri, R. Bruno, P. Sacchi, F. Baldanti, M. Di Maio, G.D. Beretta, S. Cinieri & N. Silvestris. (2023) Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). ESMO Open 8:3, pages 101215.
Crossref
Simon Galmiche, Liem Binh Luong Nguyen, Eric Tartour, Xavier de Lamballerie, Linda Wittkop, Paul Loubet & Odile Launay. (2022) Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clinical Microbiology and Infection 28:2, pages 163-177.
Crossref
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel & Guido Kroemer. (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews Clinical Oncology 17:12, pages 725-741.
Crossref
Angelika Wagner & Ursula Wiedermann-Schmidt. 2020. Onkologische Rehabilitation. Onkologische Rehabilitation 257 276 .
Yoshie Kametani, Yusuke Ohno, Shino Ohshima, Banri Tsuda, Atsushi Yasuda, Toshiro Seki, Ryoji Ito & Yutaka Tokuda. (2019) Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 20:24, pages 6337.
Crossref
Heinz Läubli, Catharina Balmelli, Lukas Kaufmann, Michal Stanczak, Mohammedyaseen Syedbasha, Dominik Vogt, Astrid Hertig, Beat Müller, Oliver Gautschi, Frank Stenner, Alfred Zippelius, Adrian Egli & Sacha I. Rothschild. (2018) Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Roni Bitterman, Noa Eliakim-Raz, Inbal Vinograd, Anca Zalmanovici Trestioreanu, Leonard Leibovici & Mical Paul. (2018) Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database of Systematic Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.